Very sparse GISAID data for late October shows FluQE31 KP.3.1.1 / MC and children down to just over half of all sequences.
FLiRT KS.1.1 / FLuQE KP.3.3 hybrid XEC now near one in eight.
JN.1 FLiRT variants LB.1 & LF.*, and FDA's vaccine target KP.2, hang on—yet losing ground.
Per previous analysis, common mutations mean that LB.1 & KP.3 both closer to KP.2 than WHO vaccine target JN.1:
https://disabled.social/@beadsland/112738436725849215
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne